Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Mitchell

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|May 9, 2025
KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastomaAnca B Mihalas, Sonali Arora, Samantha A O'Connor, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Physical Biology|January 25, 2022
Roadmap on plasticity and epigenetics in cancerJasmine Foo, David Basanta, Russell C Rockne, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Genes & Development|February 2, 2023
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastomaKelly Mitchell, Samuel A Sprowls, Sonali Arora, et al.
Nature Cancer|August 11, 2020
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathyDulguun Amgalan, Thomas P Garner, Ryan Pekson, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|May 9, 2025
KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastomaAnca B Mihalas, Sonali Arora, Samantha A O'Connor, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Physical Biology|January 25, 2022
Roadmap on plasticity and epigenetics in cancerJasmine Foo, David Basanta, Russell C Rockne, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Genes & Development|February 2, 2023
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastomaKelly Mitchell, Samuel A Sprowls, Sonali Arora, et al.
Nature Cancer|August 11, 2020
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathyDulguun Amgalan, Thomas P Garner, Ryan Pekson, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 4